Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
Maximal Early Hbv Suppression In Nucleoside-treated Hepatitis B Patients Is Associated With Optimal Virologic And Clinical Efficacy At One Year Journal:Journal of Clinical Virology | 2006 | ||
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B Journal:New England Journal of Medicine | 2005 | ||
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma Journal:Clinical Cancer Research | 2018 | ||
Telbivudine versus lamivudine in patients with chronic hepatitis B Journal:New England Journal of Medicine | 2007 |